Delcath Systems

$13.75
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.22 (+1.62%) Today
-$0.04 (-0.29%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell DCTH and other stocks, options, and ETFs commission-free!

About DCTH

Delcath Systems, Inc. Common Stock, also called Delcath Systems, is an oncology company, which focuses on the treatment of primary and metastatic liver cancers.

CEO
Gerard J. Michel
Employees
36
Headquarters
New York, New York
Founded
1988
Market Cap
88.30M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.13M
High Today
$13.93
Low Today
$13.29
Open Price
$13.68
Volume
88.73K
52 Week High
$25.18
52 Week Low
$6.06

DCTH Earnings

-$108.07
-$72.05
-$36.02
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 14, Pre-Market

You May Also Like

EFL
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure